Biological Dynamics, Inc.

41 articles about Biological Dynamics, Inc.

• Biological Dynamics Selected as Finalist for the 2022 AACC Disruptive Technology Award

  6/14/2022

  Award Recognizes the Company’s Verita ™ Isolation Platform, which Enables Early-Stage Cancer Detection.

• Biological Dynamics to Participate in Key Life Science and Healthcare Meetings

  3/31/2022

  Biological Dynamics, Inc., a biotechnology company focused on detecting diseases at the earliest stages, announced participation in a series of global events to discuss industry trends and challenges, and to preview new early-stage cancer detection data based on the company’s novel Verita™ technology.

• Biological Dynamics Study Demonstrates Detection of Early-Stage Cancers

  3/17/2022

  Biological Dynamics, Inc. announces the publication of its study, Early-Stage Multi-Cancer Detection Using an Extracellular Vesicle Protein-Based Blood Test, published in Nature Communications Medicine.

• 

  BioSpace Movers & Shakers, March 11

  3/11/2022

  Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers

• Precision Medicine Expert Dr. Paul Billings Rejoins Biological Dynamics, Inc. as Chief Executive Officer and Director

  3/8/2022

  Biological Dynamics, Inc., a novel multiomic test company focused on detecting diseases at their earliest stages, announced the return of Paul Billings, MD, PhD, FACP, FACMGG to the company as Chief Executive Officer and Director.

• FDA Grants Breakthrough Device Designation for Biological Dynamics’ Early-stage Pancreatic Cancer Detection Test

  10/20/2021

  Biological Dynamics, Inc., a multiomics liquid biopsy company focused on detecting cancers at the earliest stages, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its liquid biopsy assay, Exo-PDAC.

• Biological Dynamics to Present at UBS Genomics 2.0 and MedTech Innovations Summit

  8/6/2021

  Biological Dynamics, Inc. will present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California. The panel discussion takes place on Tuesday, August 10, 2021 at 7:00 p.m. PT.

• Biological Dynamics to Participate in the Nephron Research Liquid Biopsy Innovation Symposium

  6/15/2021

  Biological Dynamics, Inc., a next-generation liquid biopsy company focused on detecting cancers at the earliest stages, will participate in the Nephron Research Liquid Biopsy Innovation Symposium

• Biological Dynamics to Present at the 39th Annual J.P. Morgan Healthcare Conference

  1/8/2021

  Company to Webcast Presentation Tuesday, January 12, 2021 at 5:30 p.m. ET

• Biological Dynamics Appoints Kevin Han as New Chief Financial Officer

  12/22/2020

  Veteran life science investor and industry analyst brings robust financial acumen and life science sector expertise to next-generation liquid biopsy company

• Biological Dynamics Expands Biomarkers Research Into Alzheimer's With Funding From Alzheimer's Drug Discovery Foundation (ADDF)

  7/29/2020

  Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, announces a new biomarkers program designed for drug development applications in Alzheimer's D

• Biological Dynamics Initiates New Phase of Next Generation Tuberculosis Test Development

  2/20/2020

  Supplemental funding from the Bill & Melinda Gates Foundation supports study of Biological Dynamics' novel TB detection test performance using clinical samples

• Biological Dynamics Enters Collaboration to Advance Access to Novel Diagnostic Solutions to Life Science Customers

  1/28/2020

  Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced it has been accepted to Microsoft's One Commercial Partner (OCP) program.

• Biological Dynamics Receives Grant Award Funding to Advance Point-of-Care Molecular Diagnostic Platform

  6/28/2019

  Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health outcomes, today announced a new grant award from the Bill & Melinda Gates Foundation.

• Biological Dynamics to Present at Biotech Showcase 2019 During Annual J.P. Morgan Conference in San Francisco

  1/7/2019

  Biological Dynamics today announced the company will present at the Biotech Showcase™ 2019 conference, taking place during the annual J.P. Morgan Healthcare Conference on January 7-9 at the Hilton San Francisco Union Square.

• Biological Dynamics Selected as Winner of CONNECT’s 2018 Most Innovative New Product Award

  12/7/2018

  Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with accessible cancer diagnostics, today announced that its OmniVerita™ system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage category.

• Biological Dynamics Awarded Grant to Develop the Next Generation of Smartphone-Enabled Tuberculosis Tests

  11/8/2018

  Grant to help address the pressing need of reducing the burden of tuberculosis (TB) in resource-poor settings

• Biological Dynamics Selected as a Finalist for CONNECT’s 2018 Most Innovative New Product Awards

  9/26/2018

  Company’s OmniVerita Designed to Enable Early Detection and Monitoring of Cancer

• Biological Dynamics Appoints Irwin M. Jacobs as Chairman of the Board

  6/20/2018

  Dr. Jacobs is founding Chairman and CEO Emeritus of Qualcomm and Chairman Emeritus of the Salk Institute for Biological Studies.

• Biological Dynamics Announces Data Presentations at AACR Annual Meeting 2018

  4/16/2018

  Biological Dynamics, a molecular diagnostics company dedicated to improving global health outcomes by empowering global communities with low-cost, accessible cancer diagnostics, today announced that new data on the company’s novel technology (ACE) will be presented at the American Association for Cancer Research 2018 Annual Meeting, at McCormick Place Convention Center on April 13 – 18 in Chicago.